Decrease in norovirus infections in Germany following COVID-19 containment measures
- PMID: 33581238
- PMCID: PMC8711047
- DOI: 10.1016/j.jinf.2021.02.012
Decrease in norovirus infections in Germany following COVID-19 containment measures
Conflict of interest statement
Declaration of Competing Interest Ulrich Eigner and Thomas Verstraeten report consulting grants from Takeda Pharmaceuticals AG to Labor Limbach and P95. John Weil is an employee of Takeda Pharmaceuticals International AG.
Figures
Comment in
-
Potential future implications of the COVID-19 pandemic on Norovirus infections in England.J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.05.003. Epub 2021 May 13. J Infect. 2021. PMID: 33992690 Free PMC article. No abstract available.
-
Genetic diversity and persistent transmission of norovirus in Shenzhen, China, 2016-2018.J Infect. 2022 May;84(5):e89-e91. doi: 10.1016/j.jinf.2022.01.018. Epub 2022 Jan 15. J Infect. 2022. PMID: 35041921 No abstract available.
Comment on
-
Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review.J Infect. 2021 Jan;82(1):1-35. doi: 10.1016/j.jinf.2020.11.039. Epub 2020 Dec 3. J Infect. 2021. PMID: 33278399 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
